The Impact of Stereotaxy on Cognitive Domains of Patients with Glioma

Zarghi A^1, , Zali A¹, Tehranidost M², Zarindast MR², Ashrafi F¹ and Moazezi S¹

¹Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences

²Institute for Cognitive Sciences (ICSS)

Cite this paper:
Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F and Moazezi S. The Impact of Stereotaxy on Cognitive Domains of Patients with Glioma. Global Journal of Surgery. 2013; 1(4):44-49. doi: 10.12691/js-1-4-2

Abstract

Introduction: This study tries to determine the impact of stereotaxy on cognitive domains of patients with glioma. Methods and Materials: It was a cross-sectional study performed on 42 glioma patients aged from 15 to 65 years old. All of the patients were examined by neurosurgeons, neurologists and psychiatrists and then 42 patients were referred to stereotaxy. Cognitive evaluations were done through Stroop, CPT, and TOL tests. Results: Based on the performance assessment of the patients before and after stereotaxy, a significant difference was observed between Stroop, CPT and TOL tests measures (P<0.05). Conclusion: The present study indicated that cognitive impairments could be found in patients with glioma after stereotaxy so that for survival, longevity and better life quality they need cognitive rehabilitation simultaneous with stereotaxy.

Keywords:
stereotaxy cognitive domains glioma

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Aman CJ, Roberts RJ Jr, Pennington BF: A neuropsychological examination of the underlying deficit in attention deficit hyperactivity disorder: frontal lobe versus right parietal lobe theories. Dev Psychol 34: (5) 956-69, 1998.
[2]	Anderson SW, Damasio H, Tranel D: Neuropsychological impairments associated with lesions caused by tumor or stroke. Arch Neurol 47: 397-405, 1990.
[3]	Barkley, R. A. A new theory of adhd. The ADHD Report 1: 1-4, 1993.
[4]	Beck LH, Bransome ED Jr, Mirsky AF, Rosvold HE, Sarason I: A continuous performance test of brain damage. J Consult Psychol 20: (5) 343-50, 1956.
[5]	Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry 4:61-571, 1961.
[6]	Bhat SR, Goodwin TL, Burwinkle TM, et al: Profile of daily life in children with brain tumors: An assessment of health-related quality of life. J Clin Oncol 23:5493-5500, 2005.
[7]	Bosma I, Reijneveld JC, Klein M, Douw L, Van Dijk BW, Heimans JJ, Stam CJ. Disturbed functional brain networks and neurocognitive function in Low grade glioma patients: a graph theoretical analysis of resting state MEG. Nonlinear Biomed Phys 23: 3(1) 9, 2009.
[8]	Correa DD, Rocco-Donovan M, DeAngelis LM, Dolgoff-Kaspar R, Iwamoto F, Yahalom J, Abrey LE. Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J Neurooncol 91: (3) 315-21, 2009.
[9]	Cummings JL. Neuropsychiatric manifestations of right hemisphere lesions. Brain Lang 57:22-37, 1997.
[10]	Divcić B, Hajnzić TF. Neuropsychological functioning of children with brain tumors. Acta Clin Croat 47: (2) 67-75, 2008.
[11]	Ehlis AC, Herrmann MJ, Wagener A, Fallgatter AJ. Multi-channel near-infrared spectroscopy detects specific inferior-frontal activation during incongruent Stroop trials. Biol Psychol 69(3):315-31, 2005.
[12]	Eysenck HJ, Eysenck BG. Eysenck personality inventory manual. : Press, 1964.
[13]	Fox, S., , D. & Farace, E. Symptom clusters in patients with high - grade glioma. Journal of Clinical Scholarship 39:1, 61-67, 2007.
[14]	Giovagnoli AR, Silvani A, Colombo E, Boiardi A. Facets and determinants of quality of life in patients with recurrent high grade glioma. J Neurol Neurosurg Psychiatry 76:562-8, 2005.
[15]	Gratton-Smith PJ, Morris JGL, Shores EA, et al. Neuro-psychological abnormalities in patients with pituitary tumours. Acta Neurol Scand 86:626-31, 1992.
[16]	Gustafsson M, Edvardsson T, Ahlstrom G. The relationship between function, quality of life and coping in patients with low-grade gliomas. Support Care Cancer 14:1205-1212, 2006.
[17]	Heimans JJ, Taphoorn MJ. Impact of brain tumour treatment on quality of life. J Neurol 249:955-960, 2002.
[18]	Hunt SM, McKenna SP, McEwan J, et al. The Health Profile: subjective health status and medical consultations. Soc Sci Med 15:221-9, 1981.
[19]	Kaplan CP and Miner ME Relationship. Importance for patients with cerebral tumors. Brain Inj 14: 251-259, 2000.
[20]	Lange K, Robbins T., Marsden C., James M. Owen. A. & Paul G. L-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction. Psychopharmacology 107: 394-404, 1992.
[21]	Litofsky, N., Scott, M., Farace, E., Anderson, F., Meyer, C. & Huang, W. Depression in patients with high - grade glioma: results of the Glioma Outcomes Project. Journal of Neurosurgery 54: (2) 358-367, 2004.
[22]	Losier BJ, McGrath PJ, Klein RM. Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: a meta-analytic review. J Child Psychol Psychiatry 37(8):971-87, 1996.
[23]	Mainio A, Hakko H, Niemela A, Tuurinkoski T, Koivukangas J, Rasanen P. The effect of brain tumour laterality on anxiety levels among neurosurgical patients. J Neurol Neurosurg Psychiatry 74:1278-1282, 2003.
[24]	Mainio A, Hakko H, Timonen M, Niemela A, Koivukangas J, Rasanen P. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56:1234-41, 2005 [discussion 1241-2].
[25]	Mainio A, Hakko H, Niemela A, Koivukangas J, Rasanen P. Gender difference in relation to depression and quality of life among patients with a primary brain tumor. Eur Psychiatry 21:194-9, 2006.
[26]	Mainio A, Tuunanen S, Hakko H, Niemela A, Koivukangas J, Rasanen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256:516-21, 2006.
[27]	Meyers CA, Hess KR, Yung WK, Levin VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18:646-650, 2000.
[28]	Morgan MJ. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19(4):252-64, 1998.
[29]	North CA, North RB, Epstein JA, Piantadosi S, Wharam MD. Lowgrade cerebral astrocytomas. Survival and quality of life after radiation therapy. Cancer 66:6-14, 1990.
[30]	Osoba D, Brada M, Prados MD, Yung WK. Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-Oncology 2:221-228, 2000.
[31]	Owen A, Downes J, Suhukia. B, Polkey C & Robbins T. Planning and spatial working memory following frontal lobe lesions in man. NeuropsycJwlogia 28: 102 1- I034, 1990.
[32]	Passik S, Ricketts PL. Central nervous system tumors: In Psycho-oncology, Holland JC (ed.). Press: 303-313, 1998.
[33]	Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol 57:41-9, 2002.
[34]	Pennington B.F, & Ozonoff S. Executive functions and developmental psychopathology. Journal of Child Psychology and Psychiatry 37: 51-87, 1996.
[35]	Riccio CA, Reynolds CR, Lowe P, Moore JJ: The continuous performance test: a window on the neural substrates for attention? Arch Clin Neuropsychol 17: (3) 235-72, 2002.
[36]	Ris D, Noll RB. Long-term neurobehavioral outcome in pediatric brain tumor patients: Review and methodological critique. J Clin Exper Neuropsychol 16: 21-42, 1994.
[37]	Roger D, Nesshoever J. Individual diVerences in delayed heart rate recovery following stress: the role of extraversion, neurotism, and emotional control. Personality Individual DiVerences 4: 721-6, 1988.
[38]	Roman DD, Sperduto PW. Neuropsychological effect of cranial irradiation: Current knowledge and future directions. Int J Radiat Oncol Biol Physics 31: 983-998, 1995.
[39]	Rosvold HE, & Delgado JM. The effect on delayed-alternation test performance of stimulating or destroying electrically structures within the frontal lobes of the monkey’s brain. Journal of Comparative & Physiological Psychology 49: 365-372, 1956.
[40]	Siegel, B. V., Jr., Nuechterlein, K. H., Abel, L., Wu, J. C., & Buchsbaum, M. S. Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls. Schizophrenia Research 17: 85-94, 1995.
[41]	Shallice T. Specific impairments of planning. Philos Trans R Soc Lond B Biol Sci 25: 298(1089):199-209, 1982.
[42]	Speilberger CD, Gorsuch RC, Lushene RE. Manual for the state-trait anxiety inventory. : Consulting Psychologists Press, 1970.
[43]	Strandburg, R. J., Marsh, J. T., Brown, W. S., Asarnow, R. F., Guthrie, D., & Higa, J. Event-related potentials in high-functioning adult autistics: Linguistic and nonlinguistic visual information processing tasks. Neuropsychologia 31: 413-434, 1993.
[44]	Stroop JP: Studies of interference in serial verbal reactions. Journal of Experimental Psychology 18: 643-662, 1935.
[45]	Stuss DT, Floden D, Alexander MP, Levine B, Katz D. Stroop performance in focal lesion patients: dissociation of processes and frontal lobe lesion location. Neuropsychologia 39(8):771-86, 2001.
[46]	Talacchi A, Santini B, Savazzi S, Gerosa M. Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103: (3) 541-9, 2011.
[47]	Taphoorn MJ, Schiphorst AK, Snoek FJ, et al. Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36:48-54, 1994.
[48]	Van Den Bent MJ, Afra D, de Witte O. Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985-90, 2005.
[49]	Verbaten MN, Overtoom CC, Koelega HS, Swaab-Barneveld H, vanderGaag RJ, Buitelaar J, van Engeland H. Methylphenidate influences on both early and late ERP waves of ADHD children in a continuous performance test. J Abnorm Child Psychol 22(5):561-78, 1994.
[50]	Waber, D. P., Carpentieri, S. C., Klar, N., Silverman, L. B., Schwenn, M., Hurwitz, C. A., et al. Cognitive sequelae in children treated for acute lymphoblastic leukemia with dexamethasone or prednisone. Journal of Pediatric Hematology.Oncology 22: 206-213, 2000.
[51]	Warm JS. Sustain Attention in Human Performance. : John Wiley & Sons, 1984.
[52]	Wecker NS, Kramer JH, Wisniewski A, Delis DC, & Kaplan E. Age effects on executive ability. Neuropsychology 14, 409-414, 2000.
[53]	Weitzner MA, Meyers CA, Gelke CK, , Cella DF, Levin VA. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75:1151-1161, 1995.
[54]	Wen PY, Kesari S. Malignant gliomas in adults. Journal of Medicine 359:492-507, 2008.
[55]	Wrensch M, Minn Y, Chew T. Epidemiology of primary brain tumors: current concepts and review of the literature. Neurooncology 4:278-99, 2002.
[56]	Yoshida, Y., & Uchiyama, T. The clinical necessity for assessing attention deficit.hyperactivity disorder (AD.HD) symptoms in children with high-functioning pervasive developmental disorder (PDD). European Child and Adolescent Psychiatry 13, 307-314, 2004.
[57]	Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Doroodgar S, Khodadadi SM. The Relationship between Age, Sex and Education Variables with Selective, Sustained Attention and Planning through Cognitive Tasks among Healthy Adults. Basic and Clinical Neuroscience 2: (3)58-67, 2011.
[58]	Zarghi A, Zali A, Tehranidost M, Ashrafi F, Zarindast MR, Moazezi M, Khodadadi SM. Assessment of Selective Attention With CSCWT (Computerized Stroop Color-Word Test) Among Children and Adults. US-China Education Review A 1 121-127, 2012.
[59]	Zarghi A, Zali A, Tehranidost M, Zarindast MR, Ashrafi F, Khodadadi M. Comparative assessment of neuro-cognitive impairments among patients with brain tumor and healthy adults. Turkish Neurosurgery 22: (3) 309-316, 2012.